Shanghai Shenqi Pharmaceutical Investment Management , Ltd. Profit Margin

Shanghai Shenqi Pharmaceutical Investment Management , Ltd. posts a profit margin of 1.49% as of June 2026. That compares with 3.49% in the prior-year period — down 57.4% year over year. That is below the sector sector average of 13.23%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Shanghai Shenqi Pharmaceutical Investment Management , Ltd.'s profit margin was 3.49%. The latest reading is 1.49% — a 57.4% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a profit margin near 13.23% is typical. Shanghai Shenqi Pharmaceutical Investment Management , Ltd.'s 1.49% is lower that level. That is roughly 88.7% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Shanghai Shenqi Pharmaceutical Investment Management , Ltd.'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 1.49% as of June 2026; use YoY and peer views to separate noise from signal.

Context for 600613.SS's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.23%), and (3) consistency with growth and profitability. This page covers the first two; Shanghai Shenqi Pharmaceutical Investment Management , Ltd.'s other metric pages and overview cover the third.